Eko Murmur Analysis Software (EMAS) vs Tempus ECG-Low EF
AI Verdict
Choose Eko Murmur Analysis Software (EMAS) if…
Choose Eko Murmur Analysis Software if you need an AI-powered tool to quickly detect and differentiate heart murmurs in both adult and pediatric patients, directly at the point of care using a digital stethoscope. This is ideal for clinicians seeking early detection of potential heart and lung conditions, especially when recording and sharing heart sounds via a mobile app for consultation or documentation is beneficial.
View Eko Murmur Analysis Software (EMAS) →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary goal is to identify adult patients (40 years or older) at risk of heart failure by analyzing standard 12-lead ECG recordings for signs of low left ventricular ejection fraction. This tool is best suited for integration into existing healthcare facility workflows to aid clinicians in flagging patients for further cardiac evaluation based on their ECG data.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Murmur Analysis Software (EMAS) | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. | Unknown |
| Deployment | Cloud-based, Mobile App | Integrates with current ECG platforms and electronic health records (EHRs). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software (EMAS) is accessed via a mobile application and integrates wirelessly with Eko digital stethoscopes, suggesting a highly user-friendly experience at the point of care. This direct interaction and mobile accessibility likely make it more intuitive for individual clinicians compared to software integrated into broader facility workflows.
Clinical Value
TieBoth tools offer significant clinical value by providing FDA-cleared AI-powered decision support for critical cardiac conditions. EMAS differentiates heart murmurs in both adult and pediatric patients, while Tempus ECG-Low EF detects signs of low LVEF in adults at risk of heart failure. The specific clinical impact of each tool depends on the patient population and diagnostic needs, making it difficult to declare a definitive winner.
Pricing & Value
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software offers a free basic AI analysis with its mobile app, providing an accessible entry point for users to evaluate its capabilities. Full features are available through clear subscription models. In contrast, Tempus ECG-Low EF requires contacting the vendor for pricing, indicating a less transparent and potentially more complex enterprise-focused cost structure.
Enterprise Readiness
Tempus ECG-Low EFBoth tools are FDA-cleared, HIPAA compliant, and have BAAs, demonstrating foundational enterprise readiness. However, Tempus ECG-Low EF is explicitly described as 'integrated into healthcare facility workflows,' suggesting a design optimized for seamless adoption within existing hospital systems. While EMAS offers EHR-compatible PDF reports, its mobile app-centric deployment might require more bespoke integration efforts for large-scale enterprise adoption.
Innovation
TieBoth tools represent significant innovation in cardiology AI. EMAS innovates by integrating AI directly with a digital stethoscope for real-time murmur detection and differentiation at the point of care. Tempus ECG-Low EF innovates by leveraging a massive dataset of ECGs to identify a critical heart failure risk factor from existing diagnostic data. Both approaches offer novel ways to enhance cardiac care.
Support & Docs
Eko Murmur Analysis Software (EMAS)Eko Devices provides a comprehensive support center with FAQs, user manuals, troubleshooting guides, and direct contact options for its products, including EMAS. Information regarding specific support and documentation for Tempus ECG-Low EF as a standalone product is less readily available on Tempus AI's general platform, suggesting Eko offers more accessible user-focused resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Murmur Analysis Software (EMAS) | Tempus ECG-Low EF |
|---|---|---|
| Tool Name | Eko Murmur Analysis Software (EMAS) | Tempus ECG-Low EF |
| Company | Eko Devices | Tempus AI |
| Description | FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease. | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Key Functionality | Detects and differentiates heart murmurs using heart sound (PCG) and optional ECG data. | Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%) using 12-lead ECG recordings. |
| Target Patient Population | Adult and pediatric patients | Patients 40 years or older at risk of heart failure |
| Integration | Integrates with Eko digital stethoscopes (CORE 500, DUO, CORE) | Integrated into healthcare facility workflows |
Videos
Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Murmur Analysis Software (EMAS) or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.